Publikasi Scopus 2010 s/d 2022

Publikasi Scopus 2010 s/d 2022

Bachtiar I., Kheng V., Wibowo G.A., Gani R.A., Hasan I., Sanityoso A., Budhihusodo U., Lelosutan S.A.R., Martamala R., Achwan W.A., Soemoharjo S., Sulaiman A., Lesmana L.A., Tai S.
23570457700;36632383500;36676593900;23495930300;12776850800;57216938482;36631472100;35192151700;35192038200;23666330000;36633199000;57206256978;55920139300;16176322300;
Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma
2010
BMC Research Notes
3
319
21
https://www.scopus.com/inward/record.uri?eid=2-s2.0-78549285667&doi=10.1186%2f1756-0500-3-319&partnerID=40&md5=ebf3066b89e19c92d879de324c3f6072
Proteomic Division, Mochtar Riady Institute for Nanotechnology, Lippo Karawaci, Tangerang, 15811, Indonesia; Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Gastroentero-Hepatology Division, Department of Internal Medicine, Gatot Soebroto Hospital, Jakarta, Indonesia; Department of Internal Medicine, Mataram General Hospital, Mataram, Indonesia; Department of Hepatology, Klinik Hati Prof. Ali Sulaiman, Jakarta, Indonesia
Bachtiar, I., Proteomic Division, Mochtar Riady Institute for Nanotechnology, Lippo Karawaci, Tangerang, 15811, Indonesia; Kheng, V., Proteomic Division, Mochtar Riady Institute for Nanotechnology, Lippo Karawaci, Tangerang, 15811, Indonesia; Wibowo, G.A., Proteomic Division, Mochtar Riady Institute for Nanotechnology, Lippo Karawaci, Tangerang, 15811, Indonesia; Gani, R.A., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Hasan, I., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sanityoso, A., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Budhihusodo, U., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Lelosutan, S.A.R., Gastroentero-Hepatology Division, Department of Internal Medicine, Gatot Soebroto Hospital, Jakarta, Indonesia; Martamala, R., Gastroentero-Hepatology Division, Department of Internal Medicine, Gatot Soebroto Hospital, Jakarta, Indonesia; Achwan, W.A., Department of Internal Medicine, Mataram General Hospital, Mataram, Indonesia; Soemoharjo, S., Department of Internal Medicine, Mataram General Hospital, Mataram, Indonesia; Sulaiman, A., Department of Hepatology, Klinik Hati Prof. Ali Sulaiman, Jakarta, Indonesia; Lesmana, L.A., Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Tai, S., Proteomic Division, Mochtar Riady Institute for Nanotechnology, Lippo Karawaci, Tangerang, 15811, Indonesia
Background. The outcome of patients with hepatocellular carcinoma (HCC) remains poor because of late diagnosis. We determined the performances of α-1-acid glycoprotein (AAG) and des-γ-carboxy prothrombin (DCP) for the diagnosis of HCC, especially for α-fetoprotein (AFP)-low HCC. Methods. Of the 220 patients included in this retrospective study, 124 had HCC, and 61 (49%) of these were AFP-low HCC (AFP ≤ 20 ng/mL). The remaining 96 patients, including 49 with chronic hepatitis B or C and 47 with cirrhosis, were considered as control. Plasma AAG was analyzed using high performance liquid chromatography (HPLC) and confirmed using Western blot technique. Results. When all patients with HCC were evaluated, the area under receiver operating characteristic (ROC) curves for AAG (0.94, 95% CI: 0.91-0.97) and DCP (0.92, 95% CI: 0.88-0.95) were similar (P = 0.40). AAG had better area under ROC curve (0.96, 95% CI: 0.94-0.99) than DCP (0.87, 95% CI: 0.81-0.93) for AFP-low HCC (P < 0.05). At the specificity 95%, the sensitivity of AAG was higher in AFP-low HCC than in AFP-high HCC (82% and 62%, respectively). In contrast, higher sensitivity was obtained from DCP in discriminating HCC patients with low AFP than that in high AFP (57% and 90%, respectively). Conclusion. Our cross-sectional study showed that AAG was better performance in diagnosing HCC patients with low AFP, while DCP did better in those with high AFP. © 2010 Bachtiar et al; licensee BioMed Central Ltd.
The authors appreciate Prof. David Vaux (La Trobe University, Australia) and Dr. Juandy Jo (Uni-Freiburg, Germany) for critical reading. We thank Rama Dhenni, Griskalia Christine, and Shinta Soraya for sample collection and preparation. This work was supported by Mochtar Riady Institute for Nanotechnology (MRIN) Funding (Budget no. cc042/2007/08).
17560500
Article
Q2
536
7091

Unit Riset FKUI/Medical Research Unit
Gedung IMERI Tower Riset lt. 9, Jl. Salemba Raya No. 6, Jakarta Pusat, 10430
Telp. : +62 21 29189160 (ext. 201912)
E-mail : manajer.riset.fkui1@gmail.com

© 2024 Riset & Pengabdian Masyarakat. All Rights Reserved.